Ann: Submits New Information to FDA IND File for SR-aGVHD, page-119

I'm finding it amusing the distraction of whether it's 2 weeks or 4. Seriously, who cares, after a 2 year set back. I first invested in 2014 and have built up quiet the packet of shares, enough I could start to retire when they hit $18. So whether i can retire on the 15 March 2023 or 30th March doesn't matter.
my reading of the paperwork is that it will be classed as a class 2 submission based on what is classed as class 1. Whether it's 2015 or a later version, it's not going to be radically different. And it's just a distraction.
do you think silviu et al are going to stuff up a resubmission when they have an ex FDA director on board and our CMO.